Late recurrence of surgically removed prolactinomas.

Area of Science:

• Endocrinology
• Neurosurgery
• Oncology

Background:

• Prolactinomas are pituitary tumors causing hyperprolactinemia.
• Surgical resection is a primary treatment modality.
• Understanding long-term recurrence is crucial for patient management.

Purpose of the Study:

• To investigate the frequency and factors influencing late prolactinoma recurrence after surgical removal.
• To analyze recurrence rates in microadenomas versus macroadenomas.
• To explore the role of dural invasion in tumor recurrence.

Main Methods:

• Prospective observation of 24 women post-prolactinoma surgery.
• Mean follow-up of 62 months.
• Assessment of hyperprolactinemia, radiologic evidence, and histopathologic examination of tumors.

Main Results:

• High recurrence rate observed: 31% for microadenomas and 91% for macroadenomas.
• Macroadenoma recurrence occurred later (average 26 months) than microadenoma recurrence (3-9 months).
• Dural invasion was more common in patients with higher preoperative prolactin levels but did not correlate with recurrence.

Conclusions:

• Prolactinoma recurrence is frequent, particularly in macroadenomas, suggesting surgery alone may not be curative.
• A functional hypothalamic-pituitary control abnormality is a likely cause for persistent or recurrent hyperprolactinemia.
• Further research into the underlying causes of prolactinoma recurrence is warranted.